Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry

by | Jul 8, 2026 | Clinical Trials | 0 comments

​ Conditions: Multiple Myeloma; Minimal Residual Disease

Interventions: Diagnostic Test: Mass spectrometry

Sponsors: Odense University Hospital

Not yet recruiting Conditions: Multiple Myeloma; Minimal Residual Disease
Interventions: Diagnostic Test: Mass spectrometry
Sponsors: Odense University Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *